syndrome	score	normalized_score
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0444445	100.0
IMMUNODEFICIENCY 23; IMD23	0.040644138	91.44919618850477
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0396826	89.28573839282701
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.030644098	68.94913431358212
SUSAC SYNDROME	0.028739338000000003	64.66342967071293
SPINOCEREBELLAR ATAXIA TYPE 14	0.028739338000000003	64.66342967071293
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.028739338000000003	64.66342967071293
REFSUM DISEASE	0.027777800000000002	62.499971875035165
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.027777800000000002	62.499971875035165
SPINOCEREBELLAR ATAXIA TYPE 18	0.027777800000000002	62.499971875035165
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.027777800000000002	62.499971875035165
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.027777800000000002	62.499971875035165
TRIGEMINAL NEURALGIA	0.027777800000000002	62.499971875035165
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.027777800000000002	62.499971875035165
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.027777800000000002	62.499971875035165
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.027777800000000002	62.499971875035165
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.027777800000000002	62.499971875035165
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.027777800000000002	62.499971875035165
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.027777800000000002	62.499971875035165
SPINOCEREBELLAR ATAXIA TYPE 7	0.027777800000000002	62.499971875035165
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.027777800000000002	62.499971875035165
SPINOCEREBELLAR ATAXIA TYPE 37	0.027777800000000002	62.499971875035165
ABETAL34V AMYLOIDOSIS	0.027777800000000002	62.499971875035165
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.027777800000000002	62.499971875035165
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.027777800000000002	62.499971875035165
CORTICOBASAL SYNDROME	0.027777800000000002	62.499971875035165
NEUROMYELITIS OPTICA	0.027777800000000002	62.499971875035165
ARNOLD-CHIARI MALFORMATION TYPE I	0.027777800000000002	62.499971875035165
X-LINKED ADRENOLEUKODYSTROPHY	0.027777800000000002	62.499971875035165
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.027777800000000002	62.499971875035165
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.027777800000000002	62.499971875035165
MEGALOBLASTIC ANEMIA 1	0.027777800000000002	62.499971875035165
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.027777800000000002	62.499971875035165
SPINOCEREBELLAR ATAXIA TYPE 38	0.027777800000000002	62.499971875035165
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.027777800000000002	62.499971875035165
SMITH-MAGENIS SYNDROME; SMS	0.019532998	43.9491905635118
TEMPLE SYNDROME	0.019532998	43.9491905635118
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.018571459999999998	41.78573276783404
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.018571459999999998	41.78573276783404
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.018571459999999998	41.78573276783404
SMITH-MAGENIS SYNDROME	0.018571459999999998	41.78573276783404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.017628238	39.66348592064261
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.017628238	39.66348592064261
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.017628238	39.66348592064261
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0166667	37.50002812496484
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0166667	37.50002812496484
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.0166667	37.50002812496484
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.0166667	37.50002812496484
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0166667	37.50002812496484
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0166667	37.50002812496484
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.0166667	37.50002812496484
MANDIBULOACRAL DYSPLASIA	0.0166667	37.50002812496484
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0166667	37.50002812496484
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0166667	37.50002812496484
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0166667	37.50002812496484
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0166667	37.50002812496484
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0166667	37.50002812496484
GLYCOGEN STORAGE DISEASE VI	0.0166667	37.50002812496484
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	0.0166667	37.50002812496484
CEREBROTENDINOUS XANTHOMATOSIS	0.0166667	37.50002812496484
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0166667	37.50002812496484
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0166667	37.50002812496484
LARON SYNDROME	0.0166667	37.50002812496484
COG4-CDG	0.0166667	37.50002812496484
SITOSTEROLEMIA	0.0166667	37.50002812496484
HYPERLIPOPROTEINEMIA, TYPE I	0.0166667	37.50002812496484
CONGENITAL ANALBUMINEMIA	0.0166667	37.50002812496484
CITRULLINEMIA TYPE II	0.0166667	37.50002812496484
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0166667	37.50002812496484
CUSHING SYNDROME	0.0166667	37.50002812496484
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0166667	37.50002812496484
CHOLESTERYL ESTER STORAGE DISEASE	0.0166667	37.50002812496484
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0166667	37.50002812496484
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.0166667	37.50002812496484
ALAGILLE SYNDROME 1; ALGS1	0.0166667	37.50002812496484
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0166667	37.50002812496484
XANTHOMATOSIS, SUSCEPTIBILITY TO	0.0166667	37.50002812496484
HYPERCHOLESTEROLEMIA, FAMILIAL	0.0166667	37.50002812496484
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	0.0166667	37.50002812496484
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0166667	37.50002812496484
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0166667	37.50002812496484
LYSINURIC PROTEIN INTOLERANCE	0.0166667	37.50002812496484
DYSBETALIPOPROTEINEMIA	0.0166667	37.50002812496484
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.0166667	37.50002812496484
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0166667	37.50002812496484
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.0166667	37.50002812496484
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0166667	37.50002812496484
LOWE OCULOCEREBRORENAL SYNDROME	0.0166667	37.50002812496484
GLYCOGEN STORAGE DISEASE IXA	0.0166667	37.50002812496484
DISTAL MYOPATHY, TATEYAMA TYPE	0.0166667	37.50002812496484
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0166667	37.50002812496484
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.014771097999999998	33.2349289563388
9Q33.3Q34.11 MICRODELETION SYNDROME	0.013809559999999999	31.071471160661048
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.013809559999999999	31.071471160661048
48,XYYY SYNDROME	0.013809559999999999	31.071471160661048
PRIMARY CILIARY DYSKINESIA	0.013809559999999999	31.071471160661048
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.013809559999999999	31.071471160661048
47,XYY SYNDROME	0.013809559999999999	31.071471160661048
BARDET-BIEDL SYNDROME 1; BBS1	0.013809559999999999	31.071471160661048
48,XXXY SYNDROME	0.013809559999999999	31.071471160661048
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013809559999999999	31.071471160661048
CHROMOSOME 18Q DELETION SYNDROME	0.012866337999999998	28.949224313469607
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012866337999999998	28.949224313469607
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.012866337999999998	28.949224313469607
CLASSICAL EHLERS-DANLOS SYNDROME	0.011904799999999998	26.78576651779185
16P13.2 MICRODELETION SYNDROME	0.011904799999999998	26.78576651779185
BRAIN-LUNG-THYROID SYNDROME	0.011904799999999998	26.78576651779185
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	26.78576651779185
CASPASE 8 DEFICIENCY	0.011904799999999998	26.78576651779185
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	26.78576651779185
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.011904799999999998	26.78576651779185
BERNARD-SOULIER SYNDROME	0.011904799999999998	26.78576651779185
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	26.78576651779185
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	26.78576651779185
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011904799999999998	26.78576651779185
IMMUNODEFICIENCY 58; IMD58	0.011904799999999998	26.78576651779185
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	26.78576651779185
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	26.78576651779185
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	26.78576651779185
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	26.78576651779185
TRANSALDOLASE DEFICIENCY	0.011904799999999998	26.78576651779185
ALSTRÖM SYNDROME	0.011904799999999998	26.78576651779185
NETHERTON SYNDROME	0.011904799999999998	26.78576651779185
MICROFORM HOLOPROSENCEPHALY	0.011904799999999998	26.78576651779185
NETHERTON SYNDROME; NETH	0.011904799999999998	26.78576651779185
DUBOWITZ SYNDROME	0.011904799999999998	26.78576651779185
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011904799999999998	26.78576651779185
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	26.78576651779185
22Q11.2 DELETION SYNDROME	0.011904799999999998	26.78576651779185
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.011904799999999998	26.78576651779185
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	26.78576651779185
CARCINOID SYNDROME	0.011904799999999998	26.78576651779185
MUCOPOLYSACCHARIDOSIS, TYPE II	0.011904799999999998	26.78576651779185
SECKEL SYNDROME 9; SCKL9	0.011904799999999998	26.78576651779185
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	26.78576651779185
ALSTROM SYNDROME; ALMS	0.011904799999999998	26.78576651779185
48,XXYY SYNDROME	0.011904799999999998	26.78576651779185
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	26.78576651779185
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	26.78576651779185
DERMATITIS, ATOPIC	0.011904799999999998	26.78576651779185
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	26.78576651779185
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	26.78576651779185
49,XXXXY SYNDROME	0.011904799999999998	26.78576651779185
AORTIC ARCH DEFECTS	0.011904799999999998	26.78576651779185
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	26.78576651779185
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	26.78576651779185
MASTOCYTOSIS	0.011904799999999998	26.78576651779185
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	26.78576651779185
ICHTHYOSIS VULGARIS	0.011904799999999998	26.78576651779185
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	26.78576651779185
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	26.78576651779185
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	26.78576651779185
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	26.78576651779185
STÜVE-WIEDEMANN SYNDROME	0.011904799999999998	26.78576651779185
MYOTONIA PERMANENS	0.011904799999999998	26.78576651779185
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.011904799999999998	26.78576651779185
YAO SYNDROME	0.011904799999999998	26.78576651779185
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.011904799999999998	26.78576651779185
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.011904799999999998	26.78576651779185
CHILBLAIN LUPUS	0.011904799999999998	26.78576651779185
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	26.78576651779185
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.011904799999999998	26.78576651779185
PGM3-CDG	0.011904799999999998	26.78576651779185
CYSTIC FIBROSIS	0.011904799999999998	26.78576651779185
OCULO-PALATO-CEREBRAL SYNDROME	0.011904799999999998	26.78576651779185
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	26.78576651779185
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED 93	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0028662979999999998	6.449162438546951
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0028662979999999998	6.449162438546951
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0028662979999999998	6.449162438546951
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0028662979999999998	6.449162438546951
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
TETRASOMY 9P	0.0028662979999999998	6.449162438546951
WIEACKER-WOLFF SYNDROME	0.0028662979999999998	6.449162438546951
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0028662979999999998	6.449162438546951
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0028662979999999998	6.449162438546951
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028662979999999998	6.449162438546951
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0028662979999999998	6.449162438546951
SPINOCEREBELLAR ATAXIA TYPE 29	0.0028662979999999998	6.449162438546951
WITTEVEEN-KOLK SYNDROME	0.0028662979999999998	6.449162438546951
HUNTINGTON DISEASE-LIKE 1	0.0028662979999999998	6.449162438546951
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0028662979999999998	6.449162438546951
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0028662979999999998	6.449162438546951
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0028662979999999998	6.449162438546951
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028662979999999998	6.449162438546951
RING CHROMOSOME 22 SYNDROME	0.0028662979999999998	6.449162438546951
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0028662979999999998	6.449162438546951
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0028662979999999998	6.449162438546951
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0028662979999999998	6.449162438546951
NOONAN SYNDROME 6; NS6	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED 90	0.0028662979999999998	6.449162438546951
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0028662979999999998	6.449162438546951
ALG13-CDG	0.0028662979999999998	6.449162438546951
PELIZAEUS-MERZBACHER DISEASE	0.0028662979999999998	6.449162438546951
SOTOS SYNDROME 2	0.0028662979999999998	6.449162438546951
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0028662979999999998	6.449162438546951
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0028662979999999998	6.449162438546951
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0028662979999999998	6.449162438546951
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0028662979999999998	6.449162438546951
MICROTRIPLICATION 11Q24.1	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0028662979999999998	6.449162438546951
COFFIN-SIRIS SYNDROME 8; CSS8	0.0028662979999999998	6.449162438546951
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0028662979999999998	6.449162438546951
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0028662979999999998	6.449162438546951
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0028662979999999998	6.449162438546951
XQ25 DUPLICATION SYNDROME	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0028662979999999998	6.449162438546951
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0028662979999999998	6.449162438546951
MEHMO SYNDROME; MEHMO	0.0028662979999999998	6.449162438546951
SHUKLA-VERNON SYNDROME; SHUVER	0.0028662979999999998	6.449162438546951
COFFIN-SIRIS SYNDROME 2; CSS2	0.0028662979999999998	6.449162438546951
WEAVER SYNDROME	0.0028662979999999998	6.449162438546951
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028662979999999998	6.449162438546951
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0028662979999999998	6.449162438546951
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0028662979999999998	6.449162438546951
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0028662979999999998	6.449162438546951
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0028662979999999998	6.449162438546951
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0028662979999999998	6.449162438546951
PHELAN-MCDERMID SYNDROME	0.0028662979999999998	6.449162438546951
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0028662979999999998	6.449162438546951
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028662979999999998	6.449162438546951
SALLA DISEASE	0.0028662979999999998	6.449162438546951
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, X-LINKED 19	0.0028662979999999998	6.449162438546951
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0028662979999999998	6.449162438546951
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0028662979999999998	6.449162438546951
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0028662979999999998	6.449162438546951
LAMB-SHAFFER SYNDROME	0.0028662979999999998	6.449162438546951
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0028662979999999998	6.449162438546951
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0028662979999999998	6.449162438546951
JOUBERT SYNDROME 30; JBTS30	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0028662979999999998	6.449162438546951
ASPARTYLGLUCOSAMINURIA; AGU	0.0028662979999999998	6.449162438546951
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0028662979999999998	6.449162438546951
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0028662979999999998	6.449162438546951
SIALIDOSIS TYPE 2	0.0028662979999999998	6.449162438546951
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0028662979999999998	6.449162438546951
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0028662979999999998	6.449162438546951
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0028662979999999998	6.449162438546951
DESANTO-SHINAWI SYNDROME	0.0028662979999999998	6.449162438546951
AL KAISSI SYNDROME; ALKAS	0.0028662979999999998	6.449162438546951
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0028662979999999998	6.449162438546951
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0028662979999999998	6.449162438546951
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0028662979999999998	6.449162438546951
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0028662979999999998	6.449162438546951
KLEEFSTRA SYNDROME 2; KLEFS2	0.0028662979999999998	6.449162438546951
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0028662979999999998	6.449162438546951
DUBOWITZ SYNDROME	0.0028662979999999998	6.449162438546951
EMANUEL SYNDROME	0.0028662979999999998	6.449162438546951
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0028662979999999998	6.449162438546951
LUSCAN-LUMISH SYNDROME; LLS	0.0028662979999999998	6.449162438546951
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0028662979999999998	6.449162438546951
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0028662979999999998	6.449162438546951
CK SYNDROME	0.0028662979999999998	6.449162438546951
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0028662979999999998	6.449162438546951
CHROMOSOME 9P DELETION SYNDROME	0.0028662979999999998	6.449162438546951
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0028662979999999998	6.449162438546951
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0028662979999999998	6.449162438546951
PRADER-WILLI SYNDROME; PWS	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0028662979999999998	6.449162438546951
KLEEFSTRA SYNDROME	0.0028662979999999998	6.449162438546951
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0028662979999999998	6.449162438546951
EMANUEL SYNDROME	0.0028662979999999998	6.449162438546951
2P15P16.1 MICRODELETION SYNDROME	0.0028662979999999998	6.449162438546951
DISTAL MONOSOMY 12Q	0.0028662979999999998	6.449162438546951
KOOLEN-DE VRIES SYNDROME; KDVS	0.0028662979999999998	6.449162438546951
COHEN-GIBSON SYNDROME; COGIS	0.0028662979999999998	6.449162438546951
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028662979999999998	6.449162438546951
7Q11.23 MICRODUPLICATION SYNDROME	0.0028662979999999998	6.449162438546951
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0028662979999999998	6.449162438546951
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0028662979999999998	6.449162438546951
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0028662979999999998	6.449162438546951
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0028662979999999998	6.449162438546951
COFFIN-SIRIS SYNDROME 6; CSS6	0.0028662979999999998	6.449162438546951
COFFIN-SIRIS SYNDROME 7; CSS7	0.0028662979999999998	6.449162438546951
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0028662979999999998	6.449162438546951
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0028662979999999998	6.449162438546951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0028662979999999998	6.449162438546951
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0028662979999999998	6.449162438546951
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0028662979999999998	6.449162438546951
CHROMOSOME 1P36 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
HAREL-YOON SYNDROME; HAYOS	0.0028662979999999998	6.449162438546951
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0028662979999999998	6.449162438546951
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0028662979999999998	6.449162438546951
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0028662979999999998	6.449162438546951
CHROMOSOME 10Q26 DELETION SYNDROME	0.0028662979999999998	6.449162438546951
SHASHI-PENA SYNDROME; SHAPNS	0.0028662979999999998	6.449162438546951
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0028662979999999998	6.449162438546951
EPILEPSY, PYRIDOXINE-DEPENDENT	0.0028662979999999998	6.449162438546951
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0028662979999999998	6.449162438546951
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0028662979999999998	6.449162438546951
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0028662979999999998	6.449162438546951
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0028662979999999998	6.449162438546951
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028662979999999998	6.449162438546951
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0028662979999999998	6.449162438546951
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.0028662979999999998	6.449162438546951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0028662979999999998	6.449162438546951
GALACTOSE EPIMERASE DEFICIENCY	0.0028662979999999998	6.449162438546951
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0028662979999999998	6.449162438546951
TENORIO SYNDROME; TNORS	0.0028662979999999998	6.449162438546951
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0028662979999999998	6.449162438546951
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0028662979999999998	6.449162438546951
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0028662979999999998	6.449162438546951
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0028662979999999998	6.449162438546951
ADENYLOSUCCINASE DEFICIENCY	0.0028662979999999998	6.449162438546951
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0028662979999999998	6.449162438546951
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0028662979999999998	6.449162438546951
HYPERPROLINEMIA, TYPE I	0.0028662979999999998	6.449162438546951
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0028662979999999998	6.449162438546951
CHITAYAT SYNDROME	0.0028662979999999998	6.449162438546951
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0028662979999999998	6.449162438546951
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0028662979999999998	6.449162438546951
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0028662979999999998	6.449162438546951
VERVERI-BRADY SYNDROME; VERBRAS	0.0028662979999999998	6.449162438546951
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0028662979999999998	6.449162438546951
6Q16 MICRODELETION SYNDROME	0.00190476	4.285704642869197
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00190476	4.285704642869197
19P13.12 MICRODELETION SYNDROME	0.00190476	4.285704642869197
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00190476	4.285704642869197
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	4.285704642869197
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	4.285704642869197
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00190476	4.285704642869197
22Q11.2 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
GLASS SYNDROME	0.00190476	4.285704642869197
DYSTONIA 16; DYT16	0.00190476	4.285704642869197
5Q14.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.00190476	4.285704642869197
2Q23.1 MICRODELETION SYNDROME	0.00190476	4.285704642869197
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	4.285704642869197
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	4.285704642869197
15Q11Q13 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
19Q13.11 MICRODELETION SYNDROME	0.00190476	4.285704642869197
4Q21 MICRODELETION SYNDROME	0.00190476	4.285704642869197
1Q44 MICRODELETION SYNDROME	0.00190476	4.285704642869197
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.00190476	4.285704642869197
2Q32Q33 MICRODELETION SYNDROME	0.00190476	4.285704642869197
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00190476	4.285704642869197
NAGER SYNDROME	0.00190476	4.285704642869197
MASA SYNDROME	0.00190476	4.285704642869197
CLEFT LIP/PALATE	0.00190476	4.285704642869197
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	4.285704642869197
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00190476	4.285704642869197
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00190476	4.285704642869197
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	4.285704642869197
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	4.285704642869197
MONOSOMY 18P	0.00190476	4.285704642869197
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	4.285704642869197
DISTAL MONOSOMY 15Q	0.00190476	4.285704642869197
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	4.285704642869197
RETINITIS PIGMENTOSA 71; RP71	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00190476	4.285704642869197
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00190476	4.285704642869197
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	4.285704642869197
OROFACIODIGITAL SYNDROME XVII	0.00190476	4.285704642869197
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00190476	4.285704642869197
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00190476	4.285704642869197
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00190476	4.285704642869197
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00190476	4.285704642869197
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	4.285704642869197
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	4.285704642869197
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	4.285704642869197
SAUL-WILSON SYNDROME; SWILS	0.00190476	4.285704642869197
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00190476	4.285704642869197
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00190476	4.285704642869197
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00190476	4.285704642869197
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00190476	4.285704642869197
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00190476	4.285704642869197
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	4.285704642869197
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	4.285704642869197
CRANIOSYNOSTOSIS 7	0.00190476	4.285704642869197
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	4.285704642869197
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00190476	4.285704642869197
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00190476	4.285704642869197
BRACHYDACTYLY, TYPE A1, D	0.00190476	4.285704642869197
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	4.285704642869197
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00190476	4.285704642869197
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	4.285704642869197
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	4.285704642869197
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	4.285704642869197
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	4.285704642869197
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	4.285704642869197
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00190476	4.285704642869197
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	4.285704642869197
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.00190476	4.285704642869197
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	4.285704642869197
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	4.285704642869197
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00190476	4.285704642869197
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	4.285704642869197
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	4.285704642869197
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	4.285704642869197
FRAXE INTELLECTUAL DISABILITY	0.00190476	4.285704642869197
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	4.285704642869197
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	4.285704642869197
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	4.285704642869197
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00190476	4.285704642869197
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00190476	4.285704642869197
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	4.285704642869197
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	4.285704642869197
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00190476	4.285704642869197
LARYNGOTRACHEAL ANGIOMA	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	4.285704642869197
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	4.285704642869197
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00190476	4.285704642869197
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	4.285704642869197
TEMPLE SYNDROME	0.00190476	4.285704642869197
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00190476	4.285704642869197
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00190476	4.285704642869197
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	4.285704642869197
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	4.285704642869197
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00190476	4.285704642869197
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	4.285704642869197
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	4.285704642869197
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	4.285704642869197
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	4.285704642869197
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00190476	4.285704642869197
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	4.285704642869197
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00190476	4.285704642869197
CHROMOSOME 17Q12 DELETION SYNDROME	0.00190476	4.285704642869197
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00190476	4.285704642869197
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00190476	4.285704642869197
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	4.285704642869197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	4.285704642869197
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00190476	4.285704642869197
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	4.285704642869197
BILATERAL POLYMICROGYRIA	0.00190476	4.285704642869197
SMITH-FINEMAN-MYERS SYNDROME	0.00190476	4.285704642869197
MENTAL RETARDATION, X-LINKED 95	0.00190476	4.285704642869197
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	4.285704642869197
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	4.285704642869197
FG SYNDROME TYPE 1	0.00190476	4.285704642869197
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	4.285704642869197
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00190476	4.285704642869197
FG SYNDROME 2; FGS2	0.00190476	4.285704642869197
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	4.285704642869197
ASPARTYLGLUCOSAMINURIA	0.00190476	4.285704642869197
3Q27.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
ABLEPHARON MACROSTOMIA SYNDROME	0.00190476	4.285704642869197
AUTISM	0.00190476	4.285704642869197
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.00190476	4.285704642869197
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00190476	4.285704642869197
ADNP SYNDROME	0.00190476	4.285704642869197
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	4.285704642869197
13Q12.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
HSD10 DISEASE	0.00190476	4.285704642869197
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00190476	4.285704642869197
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00190476	4.285704642869197
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	4.285704642869197
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00190476	4.285704642869197
20Q11.2 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00190476	4.285704642869197
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	4.285704642869197
DISTAL MONOSOMY 10Q	0.00190476	4.285704642869197
DISTAL MONOSOMY 6P	0.00190476	4.285704642869197
DIGEORGE SYNDROME; DGS	0.00190476	4.285704642869197
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	4.285704642869197
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00190476	4.285704642869197
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
DISTAL TRISOMY 5Q	0.00190476	4.285704642869197
BARATELA-SCOTT SYNDROME	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00190476	4.285704642869197
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	4.285704642869197
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00190476	4.285704642869197
PARTINGTON SYNDROME	0.00190476	4.285704642869197
LANDAU-KLEFFNER SYNDROME	0.00190476	4.285704642869197
EPISODIC ATAXIA TYPE 1	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	4.285704642869197
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	4.285704642869197
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	4.285704642869197
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00190476	4.285704642869197
GENITOPATELLAR SYNDROME	0.00190476	4.285704642869197
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	4.285704642869197
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.00190476	4.285704642869197
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00190476	4.285704642869197
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	4.285704642869197
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	4.285704642869197
MONOSOMY 22Q13.3	0.00190476	4.285704642869197
ACERULOPLASMINEMIA	0.00190476	4.285704642869197
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00190476	4.285704642869197
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	4.285704642869197
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00190476	4.285704642869197
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00190476	4.285704642869197
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.00190476	4.285704642869197
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00190476	4.285704642869197
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00190476	4.285704642869197
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	4.285704642869197
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	4.285704642869197
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	4.285704642869197
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	4.285704642869197
HYPERLYSINEMIA, TYPE I	0.00190476	4.285704642869197
9Q21.13 MICRODELETION SYNDROME	0.00190476	4.285704642869197
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00190476	4.285704642869197
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00190476	4.285704642869197
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00190476	4.285704642869197
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00190476	4.285704642869197
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00190476	4.285704642869197
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00190476	4.285704642869197
6Q TERMINAL DELETION SYNDROME	0.00190476	4.285704642869197
MICROTIA	0.00190476	4.285704642869197
PMM2-CDG	0.00190476	4.285704642869197
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	4.285704642869197
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	4.285704642869197
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	4.285704642869197
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	4.285704642869197
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00190476	4.285704642869197
SHORT SYNDROME	0.00190476	4.285704642869197
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	4.285704642869197
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00190476	4.285704642869197
224550 DYSTONIA WITH RINGBINDEN	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00190476	4.285704642869197
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00190476	4.285704642869197
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00190476	4.285704642869197
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	4.285704642869197
PRADER-WILLI SYNDROME	0.00190476	4.285704642869197
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	4.285704642869197
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	4.285704642869197
17Q24.2 MICRODELETION SYNDROME	0.00190476	4.285704642869197
7P22.1 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
3Q29 MICRODELETION SYNDROME	0.00190476	4.285704642869197
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	4.285704642869197
11P15.4 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
OKAMOTO SYNDROME	0.00190476	4.285704642869197
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	4.285704642869197
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	4.285704642869197
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00190476	4.285704642869197
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	4.285704642869197
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00190476	4.285704642869197
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	4.285704642869197
UNILATERAL POLYMICROGYRIA	0.00190476	4.285704642869197
DUCHENNE MUSCULAR DYSTROPHY	0.00190476	4.285704642869197
SAY-BARBER-MILLER SYNDROME	0.00190476	4.285704642869197
20P13 MICRODELETION SYNDROME	0.00190476	4.285704642869197
12Q14 MICRODELETION SYNDROME	0.00190476	4.285704642869197
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00190476	4.285704642869197
7Q11.23 DUPLICATION SYNDROME	0.00190476	4.285704642869197
COG5-CDG	0.00190476	4.285704642869197
XQ12-Q13.3 DUPLICATION SYNDROME	0.00190476	4.285704642869197
PIERPONT SYNDROME	0.00190476	4.285704642869197
DE BARSY SYNDROME	0.00190476	4.285704642869197
CRI-DU-CHAT SYNDROME	0.00190476	4.285704642869197
MACHADO-JOSEPH DISEASE TYPE 1	0.00190476	4.285704642869197
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	4.285704642869197
WRINKLY SKIN SYNDROME	0.00190476	4.285704642869197
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	4.285704642869197
POSTORGASMIC ILLNESS SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	4.285704642869197
49,XYYYY SYNDROME	0.00190476	4.285704642869197
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	4.285704642869197
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	4.285704642869197
LIG4 SYNDROME	0.00190476	4.285704642869197
8P23.1 DUPLICATION SYNDROME	0.00190476	4.285704642869197
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	4.285704642869197
CORNELIA DE LANGE SYNDROME 1	0.00190476	4.285704642869197
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00190476	4.285704642869197
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	4.285704642869197
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00190476	4.285704642869197
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	4.285704642869197
1P21.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
MACHADO-JOSEPH DISEASE TYPE 2	0.00190476	4.285704642869197
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00190476	4.285704642869197
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	4.285704642869197
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	4.285704642869197
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
MOEBIUS SYNDROME; MBS	0.00190476	4.285704642869197
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00190476	4.285704642869197
16P11.2P12.2 MICRODELETION SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00190476	4.285704642869197
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	4.285704642869197
MAXILLOFACIAL DYSOSTOSIS	0.00190476	4.285704642869197
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	4.285704642869197
MENTAL RETARDATION, X-LINKED 9	0.00190476	4.285704642869197
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	4.285704642869197
16P13.11 MICRODELETION SYNDROME	0.00190476	4.285704642869197
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	4.285704642869197
16Q24.3 MICRODELETION SYNDROME	0.00190476	4.285704642869197
17Q12 MICRODUPLICATION SYNDROME	0.00190476	4.285704642869197
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00190476	4.285704642869197
15Q14 MICRODELETION SYNDROME	0.00190476	4.285704642869197
EPIDERMAL NEVUS SYNDROME	0.00190476	4.285704642869197
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00190476	4.285704642869197
SPEECH-LANGUAGE DISORDER 1	0.00190476	4.285704642869197
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	4.285704642869197
20Q13.33 MICRODELETION SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	4.285704642869197
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00190476	4.285704642869197
WIEDEMANN-STEINER SYNDROME	0.00190476	4.285704642869197
KLEEFSTRA SYNDROME	0.00190476	4.285704642869197
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00190476	4.285704642869197
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00190476	4.285704642869197
MILD CANAVAN DISEASE	0.00190476	4.285704642869197
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	4.285704642869197
49,XXXYY SYNDROME	0.00190476	4.285704642869197
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0009615380000000001	2.1634577956777554
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0009615380000000001	2.1634577956777554
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	2.1634577956777554
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	2.1634577956777554
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0009615380000000001	2.1634577956777554
OPTIC ATROPHY 11; OPA11	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0009615380000000001	2.1634577956777554
GIANT AXONAL NEUROPATHY	0.0009615380000000001	2.1634577956777554
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0009615380000000001	2.1634577956777554
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0009615380000000001	2.1634577956777554
MULTIMINICORE MYOPATHY	0.0009615380000000001	2.1634577956777554
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	2.1634577956777554
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0009615380000000001	2.1634577956777554
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	2.1634577956777554
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0009615380000000001	2.1634577956777554
PSEUDO-TORCH SYNDROME 2	0.0009615380000000001	2.1634577956777554
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	2.1634577956777554
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA TYPE 13	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0009615380000000001	2.1634577956777554
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0009615380000000001	2.1634577956777554
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0009615380000000001	2.1634577956777554
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	2.1634577956777554
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0009615380000000001	2.1634577956777554
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0009615380000000001	2.1634577956777554
RIGID SPINE SYNDROME	0.0009615380000000001	2.1634577956777554
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0009615380000000001	2.1634577956777554
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	2.1634577956777554
NON-DISTAL MONOSOMY 20Q	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	2.1634577956777554
RING CHROMOSOME 13 SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	2.1634577956777554
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0009615380000000001	2.1634577956777554
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	2.1634577956777554
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	2.1634577956777554
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0009615380000000001	2.1634577956777554
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	2.1634577956777554
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 32; JBTS32	0.0009615380000000001	2.1634577956777554
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0009615380000000001	2.1634577956777554
GRISCELLI SYNDROME TYPE 1	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	2.1634577956777554
SHWACHMAN-DIAMOND SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0009615380000000001	2.1634577956777554
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.0009615380000000001	2.1634577956777554
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	2.1634577956777554
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.0009615380000000001	2.1634577956777554
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0009615380000000001	2.1634577956777554
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	2.1634577956777554
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0009615380000000001	2.1634577956777554
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0009615380000000001	2.1634577956777554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0009615380000000001	2.1634577956777554
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0009615380000000001	2.1634577956777554
NOONAN SYNDROME 11; NS11	0.0009615380000000001	2.1634577956777554
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0009615380000000001	2.1634577956777554
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0009615380000000001	2.1634577956777554
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.0009615380000000001	2.1634577956777554
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	2.1634577956777554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	2.1634577956777554
ROIFMAN SYNDROME	0.0009615380000000001	2.1634577956777554
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	2.1634577956777554
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0009615380000000001	2.1634577956777554
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	2.1634577956777554
TRICHOTHIODYSTROPHY	0.0009615380000000001	2.1634577956777554
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	2.1634577956777554
STT3A-CDG	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0009615380000000001	2.1634577956777554
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	2.1634577956777554
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0009615380000000001	2.1634577956777554
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0009615380000000001	2.1634577956777554
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0009615380000000001	2.1634577956777554
STT3B-CDG	0.0009615380000000001	2.1634577956777554
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0009615380000000001	2.1634577956777554
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	2.1634577956777554
SALT-AND-PEPPER SYNDROME	0.0009615380000000001	2.1634577956777554
SSR4-CDG	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0009615380000000001	2.1634577956777554
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0009615380000000001	2.1634577956777554
DUPLICATION/INVERSION 15Q11	0.0009615380000000001	2.1634577956777554
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	2.1634577956777554
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0009615380000000001	2.1634577956777554
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	2.1634577956777554
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0009615380000000001	2.1634577956777554
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	2.1634577956777554
TARP SYNDROME	0.0009615380000000001	2.1634577956777554
PERIPHERAL HYPOTHYROIDISM	0.0009615380000000001	2.1634577956777554
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	2.1634577956777554
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	2.1634577956777554
OGDEN SYNDROME	0.0009615380000000001	2.1634577956777554
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0009615380000000001	2.1634577956777554
OROFACIODIGITAL SYNDROME TYPE 6	0.0009615380000000001	2.1634577956777554
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0009615380000000001	2.1634577956777554
TRISOMY 8P	0.0009615380000000001	2.1634577956777554
COG1-CDG	0.0009615380000000001	2.1634577956777554
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0009615380000000001	2.1634577956777554
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	2.1634577956777554
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	2.1634577956777554
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	2.1634577956777554
DDOST-CDG	0.0009615380000000001	2.1634577956777554
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	2.1634577956777554
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0009615380000000001	2.1634577956777554
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.0009615380000000001	2.1634577956777554
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	2.1634577956777554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0009615380000000001	2.1634577956777554
SIALURIA	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.0009615380000000001	2.1634577956777554
SYDENHAM CHOREA	0.0009615380000000001	2.1634577956777554
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	2.1634577956777554
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	2.1634577956777554
CAP MYOPATHY	0.0009615380000000001	2.1634577956777554
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	2.1634577956777554
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	2.1634577956777554
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0009615380000000001	2.1634577956777554
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	2.1634577956777554
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.0009615380000000001	2.1634577956777554
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0009615380000000001	2.1634577956777554
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0009615380000000001	2.1634577956777554
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.0009615380000000001	2.1634577956777554
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0009615380000000001	2.1634577956777554
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0009615380000000001	2.1634577956777554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.0009615380000000001	2.1634577956777554
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0009615380000000001	2.1634577956777554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0009615380000000001	2.1634577956777554
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	2.1634577956777554
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0009615380000000001	2.1634577956777554
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0009615380000000001	2.1634577956777554
XQ25 MICRODUPLICATION SYNDROME	0.0009615380000000001	2.1634577956777554
ETHYLMALONIC ENCEPHALOPATHY	0.0009615380000000001	2.1634577956777554
JABERI-ELAHI SYNDROME; JABELS	0.0009615380000000001	2.1634577956777554
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0009615380000000001	2.1634577956777554
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0009615380000000001	2.1634577956777554
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	2.1634577956777554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0009615380000000001	2.1634577956777554
8Q24.3 MICRODELETION SYNDROME	0.0009615380000000001	2.1634577956777554
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	2.1634577956777554
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	2.1634577956777554
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0009615380000000001	2.1634577956777554
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0009615380000000001	2.1634577956777554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0009615380000000001	2.1634577956777554
TEMPLE-BARAITSER SYNDROME	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	2.1634577956777554
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0009615380000000001	2.1634577956777554
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0009615380000000001	2.1634577956777554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	2.1634577956777554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0009615380000000001	2.1634577956777554
MEND SYNDROME	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	2.1634577956777554
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0009615380000000001	2.1634577956777554
NEMALINE MYOPATHY 10	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	2.1634577956777554
COFFIN-LOWRY SYNDROME; CLS	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0009615380000000001	2.1634577956777554
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0009615380000000001	2.1634577956777554
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0009615380000000001	2.1634577956777554
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	2.1634577956777554
MEND SYNDROME; MEND	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED 99	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0009615380000000001	2.1634577956777554
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0009615380000000001	2.1634577956777554
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0009615380000000001	2.1634577956777554
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.0009615380000000001	2.1634577956777554
AICARDI SYNDROME; AIC	0.0009615380000000001	2.1634577956777554
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	2.1634577956777554
CRANIOFRONTONASAL SYNDROME; CFNS	0.0009615380000000001	2.1634577956777554
CYCLIC VOMITING SYNDROME	0.0009615380000000001	2.1634577956777554
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	2.1634577956777554
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0009615380000000001	2.1634577956777554
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0009615380000000001	2.1634577956777554
TARP SYNDROME; TARPS	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	2.1634577956777554
MICROPHTHALMIA, SYNDROMIC 1	0.0009615380000000001	2.1634577956777554
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED 1	0.0009615380000000001	2.1634577956777554
MENKES DISEASE	0.0009615380000000001	2.1634577956777554
PETTIGREW SYNDROME	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED 41	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0009615380000000001	2.1634577956777554
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0009615380000000001	2.1634577956777554
SULFOCYSTEINURIA	0.0009615380000000001	2.1634577956777554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	2.1634577956777554
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	2.1634577956777554
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.0009615380000000001	2.1634577956777554
INFANTILE SIALIC ACID STORAGE DISEASE	0.0009615380000000001	2.1634577956777554
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0009615380000000001	2.1634577956777554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 3B	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0009615380000000001	2.1634577956777554
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	2.1634577956777554
PYRUVATE CARBOXYLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0009615380000000001	2.1634577956777554
PSEUDOTRISOMY 13 SYNDROME	0.0009615380000000001	2.1634577956777554
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0009615380000000001	2.1634577956777554
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0009615380000000001	2.1634577956777554
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0009615380000000001	2.1634577956777554
TAY-SACHS DISEASE; TSD	0.0009615380000000001	2.1634577956777554
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	2.1634577956777554
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	2.1634577956777554
LESCH-NYHAN SYNDROME; LNS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0009615380000000001	2.1634577956777554
LISSENCEPHALY, X-LINKED, 2	0.0009615380000000001	2.1634577956777554
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0009615380000000001	2.1634577956777554
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0009615380000000001	2.1634577956777554
ZUNICH NEUROECTODERMAL SYNDROME	0.0009615380000000001	2.1634577956777554
XYLOSIDASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0009615380000000001	2.1634577956777554
OROFACIODIGITAL SYNDROME VI	0.0009615380000000001	2.1634577956777554
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	2.1634577956777554
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	2.1634577956777554
WARBURG MICRO SYNDROME 1	0.0009615380000000001	2.1634577956777554
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	2.1634577956777554
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0009615380000000001	2.1634577956777554
KAGAMI-OGATA SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0009615380000000001	2.1634577956777554
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 2	0.0009615380000000001	2.1634577956777554
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0009615380000000001	2.1634577956777554
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0009615380000000001	2.1634577956777554
NIEMANN-PICK DISEASE, TYPE C2	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0009615380000000001	2.1634577956777554
LATHOSTEROLOSIS	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0009615380000000001	2.1634577956777554
FUMARASE DEFICIENCY; FMRD	0.0009615380000000001	2.1634577956777554
LARSEN-LIKE SYNDROME	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 3; JBTS3	0.0009615380000000001	2.1634577956777554
GENITOPATELLAR SYNDROME; GTPTS	0.0009615380000000001	2.1634577956777554
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0009615380000000001	2.1634577956777554
NEMALINE MYOPATHY 4	0.0009615380000000001	2.1634577956777554
SCHINDLER DISEASE, TYPE I	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0009615380000000001	2.1634577956777554
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0009615380000000001	2.1634577956777554
PIERSON SYNDROME	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0009615380000000001	2.1634577956777554
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0009615380000000001	2.1634577956777554
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0009615380000000001	2.1634577956777554
HYPOTONIA-CYSTINURIA SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0009615380000000001	2.1634577956777554
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0009615380000000001	2.1634577956777554
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0009615380000000001	2.1634577956777554
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	2.1634577956777554
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0009615380000000001	2.1634577956777554
PALLISTER-KILLIAN SYNDROME	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.0009615380000000001	2.1634577956777554
STUVE-WIEDEMANN SYNDROME	0.0009615380000000001	2.1634577956777554
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	2.1634577956777554
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0009615380000000001	2.1634577956777554
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0009615380000000001	2.1634577956777554
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0009615380000000001	2.1634577956777554
TIMOTHY SYNDROME; TS	0.0009615380000000001	2.1634577956777554
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0009615380000000001	2.1634577956777554
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.0009615380000000001	2.1634577956777554
CODAS SYNDROME	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	2.1634577956777554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0009615380000000001	2.1634577956777554
MARSHALL-SMITH SYNDROME; MRSHSS	0.0009615380000000001	2.1634577956777554
GLYCINE ENCEPHALOPATHY; GCE	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	2.1634577956777554
BOHRING-OPITZ SYNDROME	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	2.1634577956777554
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0009615380000000001	2.1634577956777554
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0009615380000000001	2.1634577956777554
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	2.1634577956777554
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0009615380000000001	2.1634577956777554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0009615380000000001	2.1634577956777554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0009615380000000001	2.1634577956777554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0009615380000000001	2.1634577956777554
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	2.1634577956777554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	2.1634577956777554
PEHO SYNDROME; PEHO	0.0009615380000000001	2.1634577956777554
IMMUNODEFICIENCY 49; IMD49	0.0009615380000000001	2.1634577956777554
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0009615380000000001	2.1634577956777554
C SYNDROME	0.0009615380000000001	2.1634577956777554
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	2.1634577956777554
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0009615380000000001	2.1634577956777554
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0009615380000000001	2.1634577956777554
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0009615380000000001	2.1634577956777554
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	2.1634577956777554
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0009615380000000001	2.1634577956777554
ARTERIAL TORTUOSITY SYNDROME	0.0009615380000000001	2.1634577956777554
CHIARI MALFORMATION TYPE II	0.0009615380000000001	2.1634577956777554
MICROPHTHALMIA, SYNDROMIC 3	0.0009615380000000001	2.1634577956777554
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0009615380000000001	2.1634577956777554
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
SENGERS SYNDROME	0.0009615380000000001	2.1634577956777554
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	2.1634577956777554
CEREBELLAR HYPOPLASIA	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0009615380000000001	2.1634577956777554
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0009615380000000001	2.1634577956777554
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	2.1634577956777554
TEMTAMY SYNDROME; TEMTYS	0.0009615380000000001	2.1634577956777554
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0009615380000000001	2.1634577956777554
COHEN SYNDROME	0.0009615380000000001	2.1634577956777554
COACH SYNDROME	0.0009615380000000001	2.1634577956777554
YUNIS-VARON SYNDROME	0.0009615380000000001	2.1634577956777554
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0009615380000000001	2.1634577956777554
GRISCELLI SYNDROME, TYPE 1	0.0009615380000000001	2.1634577956777554
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 1	0.0009615380000000001	2.1634577956777554
ADDUCTED THUMBS SYNDROME	0.0009615380000000001	2.1634577956777554
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0009615380000000001	2.1634577956777554
RITSCHER-SCHINZEL SYNDROME 1	0.0009615380000000001	2.1634577956777554
JACOBSEN SYNDROME	0.0009615380000000001	2.1634577956777554
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0009615380000000001	2.1634577956777554
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	2.1634577956777554
ZIMMERMANN-LABAND SYNDROME 1	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	2.1634577956777554
LATERAL MENINGOCELE SYNDROME	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	2.1634577956777554
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0009615380000000001	2.1634577956777554
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0009615380000000001	2.1634577956777554
CAMPOMELIC DYSPLASIA	0.0009615380000000001	2.1634577956777554
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	2.1634577956777554
ANGELMAN SYNDROME	0.0009615380000000001	2.1634577956777554
ADAMS-OLIVER SYNDROME 1; AOS1	0.0009615380000000001	2.1634577956777554
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	2.1634577956777554
KABUKI SYNDROME 1	0.0009615380000000001	2.1634577956777554
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	2.1634577956777554
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0009615380000000001	2.1634577956777554
ACROCALLOSAL SYNDROME; ACLS	0.0009615380000000001	2.1634577956777554
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
WILLIAMS-BEUREN SYNDROME; WBS	0.0009615380000000001	2.1634577956777554
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	2.1634577956777554
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	2.1634577956777554
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	2.1634577956777554
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0009615380000000001	2.1634577956777554
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	2.1634577956777554
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	2.1634577956777554
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.0009615380000000001	2.1634577956777554
MYOTONIC DYSTROPHY 1	0.0009615380000000001	2.1634577956777554
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	2.1634577956777554
HOLOPROSENCEPHALY 2; HPE2	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0009615380000000001	2.1634577956777554
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0009615380000000001	2.1634577956777554
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0009615380000000001	2.1634577956777554
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0009615380000000001	2.1634577956777554
MUCOLIPIDOSIS IV; ML4	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	2.1634577956777554
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0009615380000000001	2.1634577956777554
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	2.1634577956777554
METACHROMATIC LEUKODYSTROPHY	0.0009615380000000001	2.1634577956777554
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.0009615380000000001	2.1634577956777554
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0009615380000000001	2.1634577956777554
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	2.1634577956777554
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0009615380000000001	2.1634577956777554
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	2.1634577956777554
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	2.1634577956777554
PRIMROSE SYNDROME; PRIMS	0.0009615380000000001	2.1634577956777554
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	2.1634577956777554
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0009615380000000001	2.1634577956777554
NIEMANN-PICK DISEASE, TYPE A	0.0009615380000000001	2.1634577956777554
NAVAJO NEUROHEPATOPATHY	0.0009615380000000001	2.1634577956777554
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0009615380000000001	2.1634577956777554
ELEJALDE DISEASE	0.0009615380000000001	2.1634577956777554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0009615380000000001	2.1634577956777554
NEURAMINIDASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
LEIGH SYNDROME; LS	0.0009615380000000001	2.1634577956777554
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	2.1634577956777554
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0009615380000000001	2.1634577956777554
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
OHDO SYNDROME	0.0009615380000000001	2.1634577956777554
MARINESCO-SJOGREN SYNDROME; MSS	0.0009615380000000001	2.1634577956777554
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	2.1634577956777554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0009615380000000001	2.1634577956777554
MOWAT-WILSON SYNDROME; MOWS	0.0009615380000000001	2.1634577956777554
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0009615380000000001	2.1634577956777554
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	2.1634577956777554
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	2.1634577956777554
GLUTARIC ACIDEMIA I; GA1	0.0009615380000000001	2.1634577956777554
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
FOLATE MALABSORPTION, HEREDITARY	0.0009615380000000001	2.1634577956777554
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	2.1634577956777554
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	2.1634577956777554
ETHANOLAMINOSIS	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	2.1634577956777554
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0009615380000000001	2.1634577956777554
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	2.1634577956777554
HOLOPROSENCEPHALY 1; HPE1	0.0009615380000000001	2.1634577956777554
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	2.1634577956777554
MARDEN-WALKER SYNDROME	0.0009615380000000001	2.1634577956777554
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	2.1634577956777554
MAPLE SYRUP URINE DISEASE; MSUD	0.0009615380000000001	2.1634577956777554
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	2.1634577956777554
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0009615380000000001	2.1634577956777554
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0009615380000000001	2.1634577956777554
KETOADIPICACIDURIA	0.0009615380000000001	2.1634577956777554
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0009615380000000001	2.1634577956777554
ARIMA SYNDROME	0.0009615380000000001	2.1634577956777554
JOHANSON-BLIZZARD SYNDROME; JBS	0.0009615380000000001	2.1634577956777554
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0009615380000000001	2.1634577956777554
VICI SYNDROME; VICIS	0.0009615380000000001	2.1634577956777554
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0009615380000000001	2.1634577956777554
HYPOPHOSPHATASIA, INFANTILE	0.0009615380000000001	2.1634577956777554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0009615380000000001	2.1634577956777554
GOLDBERG-SHPRINTZEN SYNDROME	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 4	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.0009615380000000001	2.1634577956777554
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	2.1634577956777554
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	2.1634577956777554
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0009615380000000001	2.1634577956777554
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	2.1634577956777554
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	2.1634577956777554
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0009615380000000001	2.1634577956777554
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	2.1634577956777554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	2.1634577956777554
WHITE-SUTTON SYNDROME; WHSUS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	2.1634577956777554
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	2.1634577956777554
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	2.1634577956777554
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0009615380000000001	2.1634577956777554
HELSMOORTEL-VAN DER AA SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0009615380000000001	2.1634577956777554
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0009615380000000001	2.1634577956777554
INFANTILE LIVER FAILURE SYNDROME 1	0.0009615380000000001	2.1634577956777554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0009615380000000001	2.1634577956777554
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0009615380000000001	2.1634577956777554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0009615380000000001	2.1634577956777554
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0009615380000000001	2.1634577956777554
LISSENCEPHALY 5; LIS5	0.0009615380000000001	2.1634577956777554
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	2.1634577956777554
AICARDI-GOUTIERES SYNDROME 7	0.0009615380000000001	2.1634577956777554
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0009615380000000001	2.1634577956777554
XIA-GIBBS SYNDROME	0.0009615380000000001	2.1634577956777554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0009615380000000001	2.1634577956777554
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0009615380000000001	2.1634577956777554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 21	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0009615380000000001	2.1634577956777554
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0009615380000000001	2.1634577956777554
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0009615380000000001	2.1634577956777554
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	2.1634577956777554
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	2.1634577956777554
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0009615380000000001	2.1634577956777554
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0009615380000000001	2.1634577956777554
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0009615380000000001	2.1634577956777554
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0009615380000000001	2.1634577956777554
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0009615380000000001	2.1634577956777554
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0009615380000000001	2.1634577956777554
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 27	0.0009615380000000001	2.1634577956777554
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0009615380000000001	2.1634577956777554
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	2.1634577956777554
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	2.1634577956777554
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.0009615380000000001	2.1634577956777554
SIFRIM-HITZ-WEISS SYNDROME	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	2.1634577956777554
ZTTK SYNDROME; ZTTKS	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 28	0.0009615380000000001	2.1634577956777554
HEART AND BRAIN MALFORMATION SYNDROME	0.0009615380000000001	2.1634577956777554
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0009615380000000001	2.1634577956777554
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 24	0.0009615380000000001	2.1634577956777554
ROIFMAN SYNDROME; RFMN	0.0009615380000000001	2.1634577956777554
SMITH-KINGSMORE SYNDROME; SKS	0.0009615380000000001	2.1634577956777554
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	2.1634577956777554
RING CHROMOSOME 14 SYNDROME	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0009615380000000001	2.1634577956777554
CRANIOSYNOSTOSIS 6; CRS6	0.0009615380000000001	2.1634577956777554
AU-KLINE SYNDROME; AUKS	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0009615380000000001	2.1634577956777554
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0009615380000000001	2.1634577956777554
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0009615380000000001	2.1634577956777554
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0009615380000000001	2.1634577956777554
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0009615380000000001	2.1634577956777554
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0009615380000000001	2.1634577956777554
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0009615380000000001	2.1634577956777554
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0009615380000000001	2.1634577956777554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0009615380000000001	2.1634577956777554
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0009615380000000001	2.1634577956777554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0009615380000000001	2.1634577956777554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 26	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 25	0.0009615380000000001	2.1634577956777554
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0009615380000000001	2.1634577956777554
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0009615380000000001	2.1634577956777554
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0009615380000000001	2.1634577956777554
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0009615380000000001	2.1634577956777554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0009615380000000001	2.1634577956777554
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0009615380000000001	2.1634577956777554
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	2.1634577956777554
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	2.1634577956777554
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	2.1634577956777554
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	2.1634577956777554
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	2.1634577956777554
HADZISELIMOVIC SYNDROME	0.0009615380000000001	2.1634577956777554
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	2.1634577956777554
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0009615380000000001	2.1634577956777554
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0009615380000000001	2.1634577956777554
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0009615380000000001	2.1634577956777554
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0009615380000000001	2.1634577956777554
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 8	0.0009615380000000001	2.1634577956777554
EPILEPSY, HOT WATER, 1	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0009615380000000001	2.1634577956777554
NOONAN SYNDROME 7; NS7	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0009615380000000001	2.1634577956777554
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0009615380000000001	2.1634577956777554
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0009615380000000001	2.1634577956777554
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0009615380000000001	2.1634577956777554
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0009615380000000001	2.1634577956777554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0009615380000000001	2.1634577956777554
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	2.1634577956777554
WARSAW BREAKAGE SYNDROME; WABS	0.0009615380000000001	2.1634577956777554
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	2.1634577956777554
FONTAINE PROGEROID SYNDROME; FPS	0.0009615380000000001	2.1634577956777554
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0009615380000000001	2.1634577956777554
PITT-HOPKINS SYNDROME	0.0009615380000000001	2.1634577956777554
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 6	0.0009615380000000001	2.1634577956777554
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0009615380000000001	2.1634577956777554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0009615380000000001	2.1634577956777554
MEVALONIC ACIDURIA; MEVA	0.0009615380000000001	2.1634577956777554
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	2.1634577956777554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 5	0.0009615380000000001	2.1634577956777554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0009615380000000001	2.1634577956777554
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0009615380000000001	2.1634577956777554
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0009615380000000001	2.1634577956777554
GLUTAMINE DEFICIENCY, CONGENITAL	0.0009615380000000001	2.1634577956777554
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0009615380000000001	2.1634577956777554
POTOCKI-LUPSKI SYNDROME	0.0009615380000000001	2.1634577956777554
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.0009615380000000001	2.1634577956777554
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0009615380000000001	2.1634577956777554
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0009615380000000001	2.1634577956777554
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.0009615380000000001	2.1634577956777554
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0009615380000000001	2.1634577956777554
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0009615380000000001	2.1634577956777554
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0009615380000000001	2.1634577956777554
LISSENCEPHALY 3; LIS3	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 7	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0009615380000000001	2.1634577956777554
LEGIUS SYNDROME	0.0009615380000000001	2.1634577956777554
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0009615380000000001	2.1634577956777554
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0009615380000000001	2.1634577956777554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	2.1634577956777554
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	2.1634577956777554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	2.1634577956777554
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0009615380000000001	2.1634577956777554
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	2.1634577956777554
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0009615380000000001	2.1634577956777554
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0009615380000000001	2.1634577956777554
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0009615380000000001	2.1634577956777554
PONTINE TEGMENTAL CAP DYSPLASIA	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0009615380000000001	2.1634577956777554
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0009615380000000001	2.1634577956777554
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0009615380000000001	2.1634577956777554
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0009615380000000001	2.1634577956777554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	2.1634577956777554
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0009615380000000001	2.1634577956777554
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0009615380000000001	2.1634577956777554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0009615380000000001	2.1634577956777554
COFFIN-SIRIS SYNDROME 4; CSS4	0.0009615380000000001	2.1634577956777554
COFFIN-SIRIS SYNDROME 3; CSS3	0.0009615380000000001	2.1634577956777554
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0009615380000000001	2.1634577956777554
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
ADAMS-OLIVER SYNDROME 2; AOS2	0.0009615380000000001	2.1634577956777554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0009615380000000001	2.1634577956777554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	2.1634577956777554
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0009615380000000001	2.1634577956777554
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0009615380000000001	2.1634577956777554
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	2.1634577956777554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0009615380000000001	2.1634577956777554
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	2.1634577956777554
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	2.1634577956777554
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	2.1634577956777554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0009615380000000001	2.1634577956777554
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	2.1634577956777554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0009615380000000001	2.1634577956777554
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0009615380000000001	2.1634577956777554
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	2.1634577956777554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.0009615380000000001	2.1634577956777554
CHROMOSOME 16Q22 DELETION SYNDROME	0.0009615380000000001	2.1634577956777554
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0009615380000000001	2.1634577956777554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0009615380000000001	2.1634577956777554
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0009615380000000001	2.1634577956777554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 15	0.0009615380000000001	2.1634577956777554
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0009615380000000001	2.1634577956777554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0009615380000000001	2.1634577956777554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0009615380000000001	2.1634577956777554
JOUBERT SYNDROME 14	0.0009615380000000001	2.1634577956777554
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0009615380000000001	2.1634577956777554
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	2.1634577956777554
